Search research articles
Contact Us
Filters
Showing results (391-400 of 598) with videos related to
Page
of 60
Sort By:
Blood Cancer Journal
|
January 8, 2021
Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway
Antonella Padella, Maria Chiara Fontana, Giovanni Marconi, et al.
Haematologica
|
March 3, 2009
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
Susanne Schnittger, Ulrike Bacher, Claudia Haferlach, et al.
Journal of Leukocyte Biology
|
September 17, 2013
The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL
Magali Humbert, Elena A Federzoni, Adrian Britschgi, et al.
Journal of Cancer Research and Clinical Oncology
|
November 5, 2014
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase
Katerina Machova Polakova, Vojtech Kulvait, Adela Benesova, et al.
Haematologica
|
March 4, 2017
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm
Mohamad Jawhar, Juliana Schwaab, Manja Meggendorfer, et al.
Stroke
|
February 15, 2023
Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke
Ernst Mayerhofer, Christoph Strecker, Heiko Becker, et al.
JCO Clinical Cancer Informatics
|
May 9, 2024
Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation
Caterina Gregorio, Marta Spreafico, Saverio D'Amico, et al.
Journal of Hematopathology
|
October 9, 2025
Analysis of myeloid neoplasms with isolated trisomy 19 reveals a novel MDS subgroup characterized by the presence of ring sideroblasts, fibrosis and SRSF2 and/or ASXL1 mutations
Konnie M Hebeda, Ludmila Boudová, Maarten F Corsten, et al.
Leukemia
|
November 30, 2021
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia
Sunisa Kongkiatkamon, Simona Pagliuca, Vera Adema, et al.
Blood
|
February 7, 2012
Genetic defects in PRC2 components other than EZH2 are not common in myeloid malignancies
Leonie I Kroeze, Gorica Nikoloski, Pedro da Silva-Coelho, et al.
Page
of 60
Search research articles
Search
Showing results (391-400 of 598) with videos related to
Sort By:
Page
of 60
Blood Cancer Journal
|
January 8, 2021
Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway
Antonella Padella, Maria Chiara Fontana, Giovanni Marconi, et al.
Haematologica
|
March 3, 2009
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
Susanne Schnittger, Ulrike Bacher, Claudia Haferlach, et al.
Journal of Leukocyte Biology
|
September 17, 2013
The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL
Magali Humbert, Elena A Federzoni, Adrian Britschgi, et al.
Journal of Cancer Research and Clinical Oncology
|
November 5, 2014
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase
Katerina Machova Polakova, Vojtech Kulvait, Adela Benesova, et al.
Haematologica
|
March 4, 2017
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm
Mohamad Jawhar, Juliana Schwaab, Manja Meggendorfer, et al.
Stroke
|
February 15, 2023
Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke
Ernst Mayerhofer, Christoph Strecker, Heiko Becker, et al.
JCO Clinical Cancer Informatics
|
May 9, 2024
Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation
Caterina Gregorio, Marta Spreafico, Saverio D'Amico, et al.
Journal of Hematopathology
|
October 9, 2025
Analysis of myeloid neoplasms with isolated trisomy 19 reveals a novel MDS subgroup characterized by the presence of ring sideroblasts, fibrosis and SRSF2 and/or ASXL1 mutations
Konnie M Hebeda, Ludmila Boudová, Maarten F Corsten, et al.
Leukemia
|
November 30, 2021
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia
Sunisa Kongkiatkamon, Simona Pagliuca, Vera Adema, et al.
Blood
|
February 7, 2012
Genetic defects in PRC2 components other than EZH2 are not common in myeloid malignancies
Leonie I Kroeze, Gorica Nikoloski, Pedro da Silva-Coelho, et al.
Page
of 60